Serbian tennis star Novak Djokovic, as of late expelled from Australia because of his Covid immunization status, is fellow benefactor and greater part investor of a biotech firm fostering a Covid-19 treatment, the Danish organization’s CEO said Wednesday.
“He is one of the originators of my organization we established in June 2020,” the CEO of QuantBioRes, Ivan Loncarevic, told AFP.
As indicated by data openly accessible in the Danish business register, 34-year-old Djokovic and his significant other, Jelena, together hold a stake of 80% in QuantBioRes, which utilizes a labor force of around 20 in Denmark, Slovenia, Australia and Britain.
“We mean to foster another innovation to battle infections and safe microscopic organisms and we chose to involve Covid as a feature,” Loncarevic said.
“On the off chance that we prevail with Covid, we will prevail with other infections.”
QuantBioRes is intending to send off clinical preliminaries in the UK in the late spring, the CEO said.
The unvaccinated men’s reality number one flew out of Melbourne on Sunday after he fizzled in a last-wheeze court bid to remain and play in the initial Grand Slam of the year, where he was focusing on a record 21st significant title.
His sensational takeoff followed an extended, high-stakes fight in court between the competitor and Australian specialists that cast a dull shadow over the competition.
Reached by AFP, Djokovic’s representative declined to remark on the tennis star’s stake in the Danish biotech firm.
